The NRAS mutation is found in several cancers such as melanoma (13 ~ 25%), colorectal cancer (1 ~ 6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is known that the response to colorectal cancer drug such as Erbitux and Cetuximab decreased and the prognosis of the patient with metastatic colorectal cancer is poor if the patient has NRAS mutation.
PNAClamp™ Mutation Detection Kit NRAS
For detection of NRAS mutations in tissue biopsies
Cat. No. PNAC-1101
Other products
ExcelRT Reverse Transcription Kit II, 100 Rxn – RP1400
ExcelRT ™ reverse transcriptase is a recombinant Moloney murine leukemia...
Clinical centrifuge (DM0506)
The DM0506 DLAB 6-position clinical centrifuge allows blood and urine...
Bio – Wand ™ Personal UV Disinfectant – U1001-W
MTC's new Bio Wand™ uses ultraviolet light (265 to 280...
PCR Plates – 1010
CP 1010